JPRN-UMIN000013304
Not Yet Recruiting
Phase 1
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear. - Phase I study of CCRT with DCF for advanced ear cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- eoplasm of the external auditory canal and middle ear
- Sponsor
- Kobe University Hospital
- Enrollment
- 12
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Pregnant or lactating women or women of childbearing potential 2\) Psychosis 3\) Patients requiring systemic steroids medication 4\) HBs antigen positive 5\) HCV antibody positive 6\) HIV antibody positive 7\) Uncontrollable diabetes millutus 8\) History of myocardial infarction within three months 9\) History of unstable angina pectoris or interstitial pneumonia or fibroid lung or severe emphysema 10\) Active bacterial or fungous infection 11\) In case of judge as inadequate subjects by attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Recruiting
Phase 2
Phase II study of chemoradiotherapy combined with gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancernresectable locally advanced pancreatic cancerJPRN-UMIN000028116agoya University Pancreatic Tumor Bord25
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32